Zobrazeno 1 - 10
of 201
pro vyhledávání: ''
Publikováno v:
The Breast Journal. 27:691-699
Invasive tubular carcinoma (ITC) and invasive mucinous carcinoma (IMC) of the breast are rare histologic subtypes of breast cancer associated with favorable prognoses. The aim of our study was to investigate the outcomes for these rare subtypes using
Publikováno v:
The Breast Journal. 27:216-221
The American College of Surgeons Oncology Group Z0011 (ACOSOG Z0011) trial demonstrated no survival advantage for women with clinical T1-T2 invasive breast cancer with 1-2 positive sentinel lymph nodes (SLN) who received whole-breast radiation, and n
Publikováno v:
The Breast Journal. 27:248-251
Introduction Symptomatic presentations account for the majority of invasive breast cancer diagnoses. While the National Health Service Breast Screening Programme is subjected to strict quality control, no such system for performance monitoring exists
Publikováno v:
The Breast Journal
Autor:
Sheida Sharifi, Teresa Ann Gore, Abra H. Shen, Olivia Diamond, Musie Ghebremichael, Flora Rozhansky, Susan E. Pories, Prudence Lam, Corrine Zarwan, Margaret M. Lotz
Publikováno v:
The Breast Journal. 27:48-51
Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are markers for an increased risk of breast cancer, yet outcomes for these diagnoses are not well-documented. In this study, all breast biopsies performed for radiologic abnormalities ove
Publikováno v:
The Breast Journal. 26:1565-1571
One of the important applications of genetic testing is genetic testing of the tumor to identify non-inherited somatic mutations. The advent of high-throughput genomic and proteomic techniques has enabled characterization of genomic alterations and a
Autor:
Claudine Isaacs, Julie M. Collins
Publikováno v:
The Breast Journal. 26:1520-1527
Pathogenic mutations in BRCA1 and BRCA2 genes markedly increase the risk of breast cancer and other cancers such as ovarian/fallopian tube, pancreatic, prostate, and melanoma. Patients with BRCA1 mutations have a slightly higher lifetime risk of brea
Autor:
Gulisa Turashvili, Hannah Y Wen
Publikováno v:
The Breast Journal. 26:1199-1207
Most invasive breast cancers express hormone receptors (HR) and typically have a favorable prognosis following endocrine therapy. Patients at a higher risk of recurrence can be identified by multigene prognostic classifiers such as the 21-gene recurr
Autor:
Jonathan D. Marotti, Kristen E. Muller
Publikováno v:
The Breast Journal. 26:1123-1131
The first genotype-phenotype relationship in breast pathology developed in 1994 with the discovery of the CDH1 gene. This finding eventually provided biological insight into the characteristic morphology of invasive lobular carcinoma. Subsequent inve
Autor:
Carlotta Olivieri, Maria Rosaria Mastrangeli, Lombardi A, Valeria Vitale, Claudio Amanti, Elena Bizzaglia, Giuseppe Nigri
Publikováno v:
The Breast Journal. 26:1265-1269
In 2017, the 8th edition of American Joint Committee on Cancer (AJCC) Staging Manual released the updating of TNM. The new edition introduces changes concerning tumor classification that could have a real innovative and useful clinical impact. The pu